Literature DB >> 21328374

Hepatitis C virus subtypes circulating among intravenous drug users in Lisbon, Portugal.

Rita Almeida Calado1, Maria Raquel Rocha, Ricardo Parreira, João Piedade, Teresa Venenno, Aida Esteves.   

Abstract

Hepatitis C virus (HCV) infects 2-3% of the world population and intravenous drug consumption is the leading cause of transmission in industrialized countries. The unavailability of data on the molecular epidemiology of HCV infection in Portugal prompted the study of HCV subtypes circulating among intravenous drug users residing in the Lisbon metropolitan area and sampled about 10 years apart (1998-2000 and 2008-2009). Partial coding sequences for E1 and/or NS5B were obtained from 124 individuals with HCV viremia, both mono-infected and co-infected with HIV. Phylogenetic analysis showed that, for both time periods, the most prevalent subtypes were 1a and 3a, found, altogether, in 64.9% and 71.6% of the individuals, respectively for the first and the second sampling periods. However, genotype 4 viruses (subtypes 4a and 4d), introduced later, as inferred by comparison of intra-subtype genetic distances, were also relatively frequent even one decade ago (24.6%). This HCV subtype profile for Portuguese intravenous drug users is in agreement with those described for other southern European countries when in association with drug consumption. With the exception of subtype 1b, phylogenetic trees did not show clustering of the Portuguese sequences, but rather phylogenetic mixing of HCV sequences from different geographic origins, as described previously in other Western countries and suggestive of a large international transmission network. Consistent with the low recombination rates reported for HCV, only one sample revealed discordant subtypes for the two regions analyzed (4d in E1 and 4a in NS5B), representing a potential new recombinant that deserves further analysis.
Copyright © 2011 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21328374     DOI: 10.1002/jmv.21955

Source DB:  PubMed          Journal:  J Med Virol        ISSN: 0146-6615            Impact factor:   2.327


  17 in total

Review 1.  Hepatitis C virus genetic variability and evolution.

Authors:  Natalia Echeverría; Gonzalo Moratorio; Juan Cristina; Pilar Moreno
Journal:  World J Hepatol       Date:  2015-04-28

Review 2.  Injecting drug use: A vector for the introduction of new hepatitis C virus genotypes.

Authors:  Simona Ruta; Costin Cernescu
Journal:  World J Gastroenterol       Date:  2015-10-14       Impact factor: 5.742

3.  Origin and evolution of the unique hepatitis C virus circulating recombinant form 2k/1b.

Authors:  Jayna Raghwani; Xiomara V Thomas; Sylvie M Koekkoek; Janke Schinkel; Richard Molenkamp; Thijs J van de Laar; Yutaka Takebe; Yasuhito Tanaka; Masashi Mizokami; Andrew Rambaut; Oliver G Pybus
Journal:  J Virol       Date:  2011-11-23       Impact factor: 5.103

4.  High recombination rate of hepatitis C virus revealed by a green fluorescent protein reconstitution cell system.

Authors:  Andrea Galli; Ulrik Fahnøe; Jens Bukh
Journal:  Virus Evol       Date:  2021-12-23

Review 5.  Epidemiology of hepatitis C in Croatia in the European context.

Authors:  Tatjana Vilibic-Cavlek; Jasmina Kucinar; Bernard Kaic; Maja Vilibic; Nenad Pandak; Ljubo Barbic; Vladimir Stevanovic; Jasmina Vranes
Journal:  World J Gastroenterol       Date:  2015-08-28       Impact factor: 5.742

6.  Assessment of factors associated with the quality of life of patients living with HIV/HCV co-infection.

Authors:  Marco Pereira; Renata Fialho
Journal:  J Behav Med       Date:  2016-08-09

7.  The genotype analysis of the hepatitis C virus in Heilongjiang Province, China.

Authors:  Xue-Di Cheng; Hua-Feng Xu; Feng Wei; Li-Xin Jiang; Hai-Zhou Zhou
Journal:  Medicine (Baltimore)       Date:  2021-05-07       Impact factor: 1.889

Review 8.  Recombination in hepatitis C virus.

Authors:  Fernando González-Candelas; F Xavier López-Labrador; María Alma Bracho
Journal:  Viruses       Date:  2011-10-24       Impact factor: 5.048

9.  Hepatitis C genotype 4: genotypic diversity, epidemiological profile, and clinical relevance of subtypes in Saudi Arabia.

Authors:  Hamad I Al Ashgar; Mohammed Q Khan; Mohammed Al-Ahdal; Sahar Al Thawadi; Ahmad Salem Helmy; Ahmed Al Qahtani; Faisal M Sanai
Journal:  Saudi J Gastroenterol       Date:  2013 Jan-Feb       Impact factor: 2.485

10.  An increased diversity of HCV isolates were characterized among 393 patients with liver disease in China representing six genotypes, 12 subtypes, and two novel genotype 6 variants.

Authors:  Lin Gu; Wangxia Tong; Manqiong Yuan; Teng Lu; Chunhua Li; Ling Lu
Journal:  J Clin Virol       Date:  2013-05-21       Impact factor: 3.168

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.